September 17, 2024 September 17, 2024Categories From the Co-ChairsFrom the Co-Chairs, September 2024Fall Comis Symposium to focus on inflammation as a cause of cancer; ECOG-ACRIN readies for NCTN Grant resubmission
September 17, 2024 September 17, 2024Categories Active Clinical TrialsComboMATCH Sparks Progress: An Update on the Precision Medicine InitiativeA conversation with study chair James M. Ford, MD
September 17, 2024 September 17, 2024Categories Active Clinical TrialsTrial Spotlight: Nagi Kumar on the EA8184 Study for Men with Low-Grade Prostate Cancer on Active SurveillanceA recent amendment expands eligibility for this phase 2 trial evaluating the use of green tea catechin pills to help prevent progression
September 17, 2024 September 17, 2024Categories Trial ResultsTrial Results: ECOG-ACRIN Research Round-UpSummaries of recently published ECOG-ACRIN research results
September 17, 2024 September 17, 2024Categories News in BriefNews in Brief, September 2024Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more
September 17, 2024 September 17, 2024Categories Active Clinical TrialsNow Enrolling: PrE1702 Real-World Data Study for Patients with EGFR-Mutated Non-Small Cell Lung Cancer Not Enrolled in Clinical TrialsThis innovative real-world data study is developing an infrastructure to conduct a study comparing outcomes in patients with EGFR-mutated NSCLC receiving osimertinib with or without chemotherapy and not enrolled in a clinical trial